Zhangzhou Pientzehuang Pharmaceutical., Ltd

Shanghai Stock Exchange 600436.SS

Zhangzhou Pientzehuang Pharmaceutical., Ltd Free Cash Flow Yield on January 14, 2025: 1.71%

Zhangzhou Pientzehuang Pharmaceutical., Ltd Free Cash Flow Yield is 1.71% on January 14, 2025, a 8.04% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Zhangzhou Pientzehuang Pharmaceutical., Ltd 52-week high Free Cash Flow Yield is 1.84% on February 02, 2024, which is 7.85% above the current Free Cash Flow Yield.
Zhangzhou Pientzehuang Pharmaceutical., Ltd 52-week low Free Cash Flow Yield is 1.25% on October 08, 2024, which is -26.85% below the current Free Cash Flow Yield.
Zhangzhou Pientzehuang Pharmaceutical., Ltd average Free Cash Flow Yield for the last 52 weeks is 1.57%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

Shanghai Stock Exchange: 600436.SS

Zhangzhou Pientzehuang Pharmaceutical., Ltd

CEO	Mr. Jin Ming Huang
IPO Date	June 16, 2003
Location	China
Headquarters	Pien Tze Huang Building
Employees	2,789
Sector	Health Care
Industries Pharmaceuticals Cosmetics Drugstores & Retail Pharmacies

Description

Zhangzhou Pientzehuang Pharmaceutical., Ltd engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally. The company's products include medicines and health products, cosmetics, daily chemicals, medical apparatus and instruments, and health foods. The company is based in Zhangzhou, China. Zhangzhou Pientzehuang Pharmaceutical., Ltd is a subsidiary of Zhangzhou Jiulongjiang Group Co., Ltd.

Key trends

Past 5 years